Here's Why Guardant Health Tumbled Today
Shares of Guardant Health (NASDAQ:GH) fell as much as 10.9% today after the company reported fourth-quarter and full-year 2019 operating results. The liquid biopsy pioneer delivered an impressive year of operations. Revenue jumped 136% compared to 2018, while both operating loss and net loss improved by about $10 million in that span.
While no one is questioning the strength of operations in 2019, Wall Street analysts appear to have been caught off guard by one component of the full-year 2020 guidance. As of 12:48 p.m. EST, the growth stock had settled to a 9% loss.
Image source: Getty Images.
Source Fool.com
